CITY TALK : Verity must turn down volume

The spotlight has once again swung back on to Verity Group, the loudspeakers firm pioneering a revolutionary new flat panel technology.

Its shares have continued their ascent of recent months, and rose another five per cent in the last fortnight, to 52.5p. For most of last year, they had trundled along at under 15p.

The latest news to affect the price came last Tuesday when the firm announced a cross-licensing deal with Noise Cancellation Technologies, a company quoted on Nasdaq in the US.

The deal means the two companies will share their technology, and Verity will pay NCT an up-front royalty fee of $3m (pounds 2m).

Verity has already signed up with NEC, the giant Japanese consumer electronics and personal computing firm, for its technology to be used in its lap- top computers. It all sounds pretty encouraging on paper, and the company is almost certainly doing the right thing when it licenses the technology, rather than try to go it alone.

However, the shares have attracted all sorts of hyperbole, and some of the recent buying has left a suspicious whiff of a stockmarket ramp in action.

The annual worldwide market for loudspeakers is worth a little over pounds 1.7bn. Verity could say justifiably that its technology will be used in items such as laptop computers and mobile phones, which fall outside the conventional speaker market.

Most commercial royalties pay a 3 per cent fee on sales of another company's technology. If that were the case, a back-of-the-envelope calculation suggests that worldwide sales for the new technology will need to top pounds 400m if Verity is to generate pounds 12m in royalty income, and thereby merit its stockmarket tag of pounds 147m - a tall order.

The original speakers and percussion business is worth about pounds 15m to pounds 20m, leaving pounds 120m plus in hopes.

With royalty income of pounds 12m, after central administration costs and tax, say there is pounds 6m left over, putting the shares on a ratio of 20 times 1998 earnings - which is just about right.

Can Verity do it? It seems unlikely - fee income of, at best, pounds 8m by 1998 looks more reasonable. The shares look over-priced, and it is time the market took a more sensible view on this company's financial prospects.

Later this month will see maiden results from LucasVarity, following the merger of the two concerns, under chief executive Victor Rice. Observers are convinced it will announce details of a long mooted share buyback, which will probably be accompanied by a cut of the 7p dividend. There is an argument that some of the surplus cash from this move and cost-cutting will be best returned to shareholders through a share buyback, and LucasVarity has said its leading shareholders approve the move. Share buybacks are a US favourite - which, given LucasVarity's quasi-US status, lends the story credibility.

Tomorrow the market will hear how Manchester United has performed off the field, when it reports its interim results for the six months to the end of January. The range of forecasts is for pre-tax profits of pounds 15.3m to pounds 16m before transfer fees, against pounds 11m last time. Transfer fees are expected to notch up pounds 3.8m, down from the first half figure last year of pounds 4.2m. One boost will come from higher gate receipts; the six months is the first full period since capacity at Old Trafford was increased to 54,000.

The results have been brought forward a day because the club plays the first leg of its European Champions League semi-final against Borussia Dortmund on Tuesday.

The bio-tech merry-go-round continues unabated, with Drew Scientific the latest boy wonder to grab the market's attention. The company had to announce it was working on a new marker for heart disease, after the shares went into orbit over the last few days. They soared another 32.5p on Friday, to 195p.

Given the recent ups and downs in the sector, it is clear that the best approach for wannabe biotech investors is to select a judicious portfolio of shares, and spread some of the risk around.

Pity shareholders in Alpha Omikron, the company with assets ranging from a Hungarian syringe factory to a Russian publishing concern. It was booted off the AIM on Thursday, after its nominated adviser, Henderson Crosthwaite, resigned. The company has had problems proving its assets exceed liabilities, and the future looks bleak. It is a warning, if one were needed, that while the AIM, set up to serve fledgling companies, can offer rich rewards to well-informed investors, equally purchasers must be prepared for the worst.

Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
Brendan O'Carroll as Agnes Brown in the 2014 Mrs Brown's Boys Christmas special
tvCould Mrs Brown's Boys have taken lead for second year?
Arts and Entertainment
Madonna is not in Twitter's good books after describing her album leak as 'artistic rape and terrorism'
music14 more 'Rebel Heart' tracks leaked including Pharrell Williams collaboration
Arts and Entertainment
Jack O'Connell stars as Louis Zamperini in Angelina Jolie's Unbroken
film review... even if Jack O'Connell is excellent
News
peopleIt seems you can't silence Katie Hopkins, even on Christmas Day...
PROMOTED VIDEO
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Selby Jennings: Oil Operations

Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...

The Jenrick Group: Night Shift Operations Manager

£43500 per annum + pension + holidays: The Jenrick Group: Night Shift Operatio...

SThree: Trainee Recruitment Consultant - LONDON

£20000 - £25000 per annum + OTE £40,000 + Car + Pension: SThree: SThree are a ...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £35K: SThree: We consistently strive to be the...

Day In a Page

A Christmas without hope: Fears grow in Gaza that the conflict with Israel will soon reignite

Christmas without hope

Gaza fears grow that conflict with Israel will soon reignite
After 150 years, you can finally visit the grisliest museum in the country

The 'Black Museum'

After 150 years, you can finally visit Britain's grisliest museum
No ho-ho-hos with Nick Frost's badass Santa

No ho-ho-hos with Nick Frost's badass Santa

Doctor Who Christmas Special TV review
Chilly Christmas: Swimmers take festive dip for charity

Chilly Christmas

Swimmers dive into freezing British waters for charity
Veterans' hostel 'overwhelmed by kindness' for festive dinner

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Isis in Iraq: Yazidi girls killing themselves to escape rape and imprisonment by militants

'Jilan killed herself in the bathroom. She cut her wrists and hanged herself'

Yazidi girls killing themselves to escape rape and imprisonment
Ed Balls interview: 'If I think about the deficit when I'm playing the piano, it all goes wrong'

Ed Balls interview

'If I think about the deficit when I'm playing the piano, it all goes wrong'
He's behind you, dude!

US stars in UK panto

From David Hasselhoff to Jerry Hall
Grace Dent's Christmas Quiz: What are you – a festive curmudgeon or top of the tree?

Grace Dent's Christmas Quiz

What are you – a festive curmudgeon or top of the tree?
Nasa planning to build cloud cities in airships above Venus

Nasa planning to build cloud cities in airships above Venus

Planet’s surface is inhospitable to humans but 30 miles above it is almost perfect
Surrounded by high-rise flats is a little house filled with Lebanon’s history - clocks, rifles, frogmen’s uniforms and colonial helmets

Clocks, rifles, swords, frogmen’s uniforms

Surrounded by high-rise flats is a little house filled with Lebanon’s history
Return to Gaza: Four months on, the wounds left by Israel's bombardment have not yet healed

Four months after the bombardment, Gaza’s wounds are yet to heal

Kim Sengupta is reunited with a man whose plight mirrors the suffering of the Palestinian people
Gastric surgery: Is it really the answer to the UK's obesity epidemic?

Is gastric surgery really the answer to the UK's obesity epidemic?

Critics argue that it’s crazy to operate on healthy people just to stop them eating
Homeless Veterans appeal: Christmas charity auction Part 2 - now LIVE

Homeless Veterans appeal: Christmas charity auction

Bid on original art, or trips of a lifetime to Africa or the 'Corrie' set, and help Homeless Veterans
Pantomime rings the changes to welcome autistic theatre-goers

Autism-friendly theatre

Pantomime leads the pack in quest to welcome all